31635333|t|Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy.
31635333|a|Colorectal patients generally have the maximum counts of Fusobacterium nucleatum (F. nucleatum) in tumors and elevate colorectal adenomas and carcinomas, which show the lowest rate of human survival. Hence, F. nucleatum is a diagnostic marker of colorectal cancer (CRC). Studies demonstrated that targeting fusobacterial Fap2 or polysaccharide of the host epithelium may decrease fusobacteria count in the CRC. Attenuated F. nucleatum-Fap2 prevents transmembrane signals and inhibits tumorigenesis inducing mechanisms. Hence, in this review, we hypothesized that application of genetically programmed fusobacterium can be skillful and thus reduce fusobacterium in the CRC. Genetically programmed F. nucleatum is a promising antitumor strategy.
31635333	21	44	Fusobacterium nucleatum	Species	851
31635333	54	71	Colorectal Cancer	Disease	MESH:D015179
31635333	92	100	patients	Species	9606
31635333	138	161	Fusobacterium nucleatum	Species	851
31635333	163	175	F. nucleatum	Species	851
31635333	180	186	tumors	Disease	MESH:D009369
31635333	199	233	colorectal adenomas and carcinomas	Disease	MESH:C563365
31635333	265	270	human	Species	9606
31635333	288	300	F. nucleatum	Species	851
31635333	327	344	colorectal cancer	Disease	MESH:D015179
31635333	346	349	CRC	Disease	MESH:D015179
31635333	410	424	polysaccharide	Chemical	MESH:D011134
31635333	461	473	fusobacteria	Species	203490
31635333	487	490	CRC	Disease	MESH:D015179
31635333	503	515	F. nucleatum	Species	851
31635333	565	578	tumorigenesis	Disease	MESH:D063646
31635333	682	695	fusobacterium	Species	851
31635333	728	741	fusobacterium	Species	851
31635333	749	752	CRC	Disease	MESH:D015179
31635333	777	789	F. nucleatum	Species	851
31635333	Association	MESH:D011134	MESH:D015179

